In the phase 3 OCEANIC-STROKE study (NCT05686070), asundexian (Bayer), an investigational, once-daily,...
by Rose Hoban, North Carolina Health News
December 15, 2025
In the phase 3 OCEANIC-STROKE study (NCT05686070), asundexian (Bayer), an investigational, once-daily,...